Gene · 3921
NIH grants1,143
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 1,143
Download this page as JSON| Grant | Title | RPSA papers | Newest fiscal year |
|---|---|---|---|
| I01CX000497 | Rescuing the ruminating brain: Identifying biomarkers of rumination and mindfulness through concurrent EEG and fMRI studies of schizophrenia and depression | 1 | 2022 |
| P01AI034533 | Flavivirus Infections: Pathogenesis and Prevention | 1 | 2022 |
| P01AI062885 | Epithelial innate signaling in airway inflammation and remodeling | 1 | 2022 |
| P30DK079337 | UAB-UCSD O'Brien Center for Acute Kidney Injury Research | 1 | 2022 |
| P30DK081943 | University of Michigan O'Brien Kidney Translational Core Center | 1 | 2022 |
| P30DK114857 | Kidney Therapeutics: Translating Discoveries into Prevention, Treatment and Cures for Kidney Diseases | 1 | 2022 |
| P41EB015922 | Laboratory of Neuro Imaging Resource (LONIR) | 1 | 2022 |
| R00AG054573 | Exploring the genetic basis of AD progression | 1 | 2022 |
| R01AG058630 | Revealing muscle stem cell heterogeneity in mice and humans through deep single-cell analysis | 1 | 2022 |
| R01AG059874 | High resolution mapping of the genetic risk for disease in the aging brain | 1 | 2022 |
| R01AG062359 | Systematic elucidation of endosomal trafficking as a therapeutic opportunity in AD using CRISPR-based functional genomics | 1 | 2022 |
| R01AI069000 | Roles for microRNA-122 and circular RNAs in flavivirus RNA amplification | 1 | 2022 |
| R01AI073755 | Antibody-based Protection against Flavivirses | 1 | 2022 |
| R01AI106398 | Target based discovery of next generation pyrazinamide | 1 | 2022 |
| R01AI130222 | Leishmania RNA viruses and pathogenesis | 1 | 2022 |
| R01AI140718 | Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV | 1 | 2022 |
| R01DA046170 | Systems biology of RNA Modifications in HIV/AIDS and Substance Use Disorders | 1 | 2022 |
| R01DA046204 | Identification of small molecules for neurological complications of HIV and substance abuse comorbidity | 1 | 2022 |
| R01DE026870 | Targeting the EGFR-PI3K/mTOR Signaling Circuitry: A Network-Based Approach for Oral Cancer Precision Therapy | 1 | 2022 |
| R01DK104998 | Regulation of Hepatic Macronutrient Metabolism by Mitochondrial Citrate Transport | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3921/grants?page=15